バイオシミュレーション技術の世界市場

◆英語タイトル:Bio Simulation Technology - Global Market Outlook (2015-2022)
◆商品コード:SMRC65032
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年4月
◆ページ数:145
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥473,100見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥598,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、バイオシミュレーション技術の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・バイオシミュレーション技術の世界市場:製品別分析/市場規模
・バイオシミュレーション技術の世界市場:需要先別分析/市場規模
・バイオシミュレーション技術の世界市場:地域別分析/市場規模
・バイオシミュレーション技術のアメリカ市場規模予測
・バイオシミュレーション技術のヨーロッパ市場規模予測
・バイオシミュレーション技術のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the biologics and biosimilars markets, increased use of personalized medicines, technological advancements and periodic product upgradation are the key factors vitalizing the market growth. However, lack of standardization, high R&D costs associated with development of biosimulation software and lack of skilled professionals are some of the major restraints hampering the market growth. Industrial bioprocessing, nutraceuticals, agri-food production and biosimulation in the defense will provide opportunities for market growth over the forecast period.
Pharmaceutical and biotechnology companies segment is valued to account largest share across the global market. North America is anticipated to command the largest share and Europe is expected to register the highest growth due to increasing government funding and the large number of pharmaceuticals and biotechnology companies in this region.

Some of the key players in this market include Certara USA Inc., Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC, Rhenovia Pharma Ltd., Insilico biosciences, Archimedes, Insilico biotechnology, Accelrys, LeadScope and Compugen.

Application Covered:
• Application In Drug Development
o Clinical Trials
o Preclinical Testing
• In Patient Validation
• Application In Drug Discovery
o Target Validation
o Target Identification
o Lead Identification/Discovery
o Lead Optimization

Product Covered:
• Software
o Toxicity Prediction Software
o Molecular Modeling and Simulation Software
o Trial Design Software
o PK/PD Modeling and Simulation Software
o Pbpk Modeling and Simulation Software
o Other Software
• Services
o External/Contract Services
o In-House Services

End user Covered:
• Regulatory Authorities
• Academic and Government Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Regulatory Guidelines
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bio Simulation Technology Market, By Application
5.1 Introduction
5.2 Application In Drug Development
5.2.1 Clinical Trials
5.2.1.1 Phase I Clinical Trial
5.2.1.2 Phase Ii Clinical Trial
5.2.1.3 Phase Iii Clinical Trial
5.2.2 Preclinical Testing
5.2.2.1 PK/PD
5.2.2.2 ADME/TOX
5.3 In Patient Validation
5.4 Application In Drug Discovery
5.4.1 Target Validation
5.4.1.1 Molecular Modeling
5.4.2 Target Identification
5.4.2.1 Protein Structure Prediction
5.4.3 Lead Identification/Discovery
5.4.3.1 De Novo Design
5.4.4 Lead Optimization
5.4.4.1 Qsar (Quantitative Structure–Activity Relationship) Models

6 Global Bio Simulation Technology Market, By Product
6.1 Introduction
6.2 Software
6.2.1 Toxicity Prediction Software
6.2.2 Molecular Modeling and Simulation Software
6.2.3 Trial Design Software
6.2.4 PK/PD Modeling and Simulation Software
6.2.5 Pbpk Modeling and Simulation Software
6.2.6 Other Software
6.3 Services
6.3.1 External/Contract Services
6.3.2 In-House Services

7 Global Bio Simulation Technology Market, By End user
7.1 Introduction
7.2 Regulatory Authorities
7.3 Academic and Government Research Institutes
7.4 Pharmaceutical and Biotechnology Companies
7.5 Contract Research Organizations

8 Global Bio Simulation Technology Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Certara USA, Inc.
10.2 Simulation Plus Inc.
10.3 Dassault Systèmes SA
10.4 Schrödinger Inc.
10.5 Advanced Chemistry Development, Inc.
10.6 Chemical Computing Group, Inc.
10.7 Entelos Holding Corporation
10.8 Genedata Ag
10.9 Physiomics PLC
10.10 Rhenovia Pharma Ltd.
10.11 Insilico biosciences
10.12 Archimedes
10.13 Insilico biotechnology
10.14 Accelrys
10.15 LeadScope
10.16 Compugen

List of Tables
Table 1 Global Bio Simulation Technology Market Outlook, By Region (2015-2022) ($MN)
Table 2 Global Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
Table 3 Global Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
Table 4 Global Bio Simulation Technology Market Outlook, By Clinical Trials (2015-2022) ($MN)
Table 5 Global Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
Table 6 Global Bio Simulation Technology Market Outlook, By In Patient Validation (2015-2022) ($MN)
Table 7 Global Bio Simulation Technology Market Outlook, By Application In Drug Discovery (2015-2022) ($MN)
Table 8 Global Bio Simulation Technology Market Outlook, By Target Validation (2015-2022) ($MN)
Table 9 Global Bio Simulation Technology Market Outlook, By Target Identification (2015-2022) ($MN)
Table 10 Global Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (2015-2022) ($MN)
Table 11 Global Bio Simulation Technology Market Outlook, By Lead Optimization (2015-2022) ($MN)
Table 12 Global Bio Simulation Technology Market Outlook, By Product (2015-2022) ($MN)
Table 13 Global Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
Table 14 Global Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
Table 15 Global Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
Table 16 Global Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
Table 17 Global Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
Table 18 Global Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
Table 19 Global Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
Table 20 Global Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
Table 21 Global Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
Table 22 Global Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
Table 23 Global Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
Table 24 Global Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
Table 25 Global Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (2015-2022) ($MN)
Table 26 Global Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
Table 27 Global Bio Simulation Technology Market Outlook, By Contract Research Organizations (2015-2022) ($MN)
Table 28 North America Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
Table 29 North America Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
Table 30 North America Bio Simulation Technology Market Outlook, By Clinical Trials (2015-2022) ($MN)
Table 31 North America Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
Table 32 North America Bio Simulation Technology Market Outlook, By In Patient Validation (2015-2022) ($MN)
Table 33 North America Bio Simulation Technology Market Outlook, By Application In Drug Discovery (2015-2022) ($MN)
Table 34 North America Bio Simulation Technology Market Outlook, By Target Validation (2015-2022) ($MN)
Table 35 North America Bio Simulation Technology Market Outlook, By Target Identification (2015-2022) ($MN)
Table 36 North America Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (2015-2022) ($MN)
Table 37 North America Bio Simulation Technology Market Outlook, By Lead Optimization (2015-2022) ($MN)
Table 38 North America Bio Simulation Technology Market Outlook, By Product (2015-2022) ($MN)
Table 39 North America Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
Table 40 North America Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
Table 41 North America Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
Table 42 North America Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
Table 43 North America Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
Table 44 North America Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
Table 45 North America Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
Table 46 North America Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
Table 47 North America Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
Table 48 North America Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
Table 49 North America Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
Table 50 North America Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
Table 51 North America Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (2015-2022) ($MN)
Table 52 North America Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
Table 53 North America Bio Simulation Technology Market Outlook, By Contract Research Organizations (2015-2022) ($MN)
Table 54 Europe Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
Table 55 Europe Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
Table 56 Europe Bio Simulation Technology Market Outlook, By Clinical Trials (2015-2022) ($MN)
Table 57 Europe Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
Table 58 Europe Bio Simulation Technology Market Outlook, By In Patient Validation (2015-2022) ($MN)
Table 59 Europe Bio Simulation Technology Market Outlook, By Application In Drug Discovery (2015-2022) ($MN)
Table 60 Europe Bio Simulation Technology Market Outlook, By Target Validation (2015-2022) ($MN)
Table 61 Europe Bio Simulation Technology Market Outlook, By Target Identification (2015-2022) ($MN)
Table 62 Europe Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (2015-2022) ($MN)
Table 63 Europe Bio Simulation Technology Market Outlook, By Lead Optimization (2015-2022) ($MN)
Table 64 Europe Bio Simulation Technology Market Outlook, By Product (2015-2022) ($MN)
Table 65 Europe Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
Table 66 Europe Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
Table 67 Europe Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
Table 68 Europe Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
Table 69 Europe Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
Table 70 Europe Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
Table 71 Europe Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
Table 72 Europe Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
Table 73 Europe Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
Table 74 Europe Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
Table 75 Europe Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
Table 76 Europe Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
Table 77 Europe Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (2015-2022) ($MN)
Table 78 Europe Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
Table 79 Europe Bio Simulation Technology Market Outlook, By Contract Research Organizations (2015-2022) ($MN)
Table 80 Asia pacific Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
Table 81 Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
Table 82 Asia pacific Bio Simulation Technology Market Outlook, By Clinical Trials (2015-2022) ($MN)
Table 83 Asia pacific Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
Table 84 Asia pacific Bio Simulation Technology Market Outlook, By In Patient Validation (2015-2022) ($MN)
Table 85 Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Discovery (2015-2022) ($MN)
Table 86 Asia pacific Bio Simulation Technology Market Outlook, By Target Validation (2015-2022) ($MN)
Table 87 Asia pacific Bio Simulation Technology Market Outlook, By Target Identification (2015-2022) ($MN)
Table 88 Asia pacific Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (2015-2022) ($MN)
Table 89 Asia pacific Bio Simulation Technology Market Outlook, By Lead Optimization (2015-2022) ($MN)
Table 90 Asia pacific Bio Simulation Technology Market Outlook, By Product (2015-2022) ($MN)
Table 91 Asia pacific Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
Table 92 Asia pacific Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
Table 93 Asia pacific Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
Table 94 Asia pacific Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
Table 95 Asia pacific Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
Table 96 Asia pacific Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
Table 97 Asia pacific Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
Table 98 Asia pacific Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
Table 99 Asia pacific Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
Table 100 Asia pacific Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
Table 101 Asia pacific Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
Table 102 Asia pacific Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
Table 103 Asia pacific Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (2015-2022) ($MN)
Table 104 Asia pacific Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
Table 105 Asia pacific Bio Simulation Technology Market Outlook, By Contract Research Organizations (2015-2022) ($MN)
Table 106 Rest of the World Bio Simulation Technology Market Outlook, By Application (2015-2022) ($MN)
Table 107 Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Development (2015-2022) ($MN)
Table 108 Rest of the World Bio Simulation Technology Market Outlook, By Clinical Trials (2015-2022) ($MN)
Table 109 Rest of the World Bio Simulation Technology Market Outlook, By Preclinical Testing (2015-2022) ($MN)
Table 110 Rest of the World Bio Simulation Technology Market Outlook, By In Patient Validation (2015-2022) ($MN)
Table 111 Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Discovery (2015-2022) ($MN)
Table 112 Rest of the World Bio Simulation Technology Market Outlook, By Target Validation (2015-2022) ($MN)
Table 113 Rest of the World Bio Simulation Technology Market Outlook, By Target Identification (2015-2022) ($MN)
Table 114 Rest of the World Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (2015-2022) ($MN)
Table 115 Rest of the World Bio Simulation Technology Market Outlook, By Lead Optimization (2015-2022) ($MN)
Table 116 Rest of the World Bio Simulation Technology Market Outlook, By Product (2015-2022) ($MN)
Table 117 Rest of the World Bio Simulation Technology Market Outlook, By Software (2015-2022) ($MN)
Table 118 Rest of the World Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (2015-2022) ($MN)
Table 119 Rest of the World Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (2015-2022) ($MN)
Table 120 Rest of the World Bio Simulation Technology Market Outlook, By Trial Design Software (2015-2022) ($MN)
Table 121 Rest of the World Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (2015-2022) ($MN)
Table 122 Rest of the World Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (2015-2022) ($MN)
Table 123 Rest of the World Bio Simulation Technology Market Outlook, By Other Software (2015-2022) ($MN)
Table 124 Rest of the World Bio Simulation Technology Market Outlook, By Services (2015-2022) ($MN)
Table 125 Rest of the World Bio Simulation Technology Market Outlook, By External/Contract Services (2015-2022) ($MN)
Table 126 Rest of the World Bio Simulation Technology Market Outlook, By In-House Services (2015-2022) ($MN)
Table 127 Rest of the World Bio Simulation Technology Market Outlook, By End user (2015-2022) ($MN)
Table 128 Rest of the World Bio Simulation Technology Market Outlook, By Regulatory Authorities (2015-2022) ($MN)
Table 129 Rest of the World Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (2015-2022) ($MN)
Table 130 Rest of the World Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (2015-2022) ($MN)
Table 131 Rest of the World Bio Simulation Technology Market Outlook, By Contract Research Organizations (2015-2022) ($MN)



【レポートのキーワード】

バイオシミュレーション技術、バイオシミュレーションソフトウェア、バイオシミュレーションサービス、毒性予測、分子モデリング

★調査レポート[バイオシミュレーション技術の世界市場]販売に関する免責事項
★調査レポート[バイオシミュレーション技術の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆